Form 8-K - Current report:
SEC Accession No. 0000950170-23-049046
Filing Date
2023-09-21
Accepted
2023-09-20 19:09:16
Documents
13
Period of Report
2023-09-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eldn-20230920.htm   iXBRL 8-K 47268
2 EX-10.1 eldn-ex10_1.htm EX-10.1 150254
  Complete submission text file 0000950170-23-049046.txt   339915

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eldn-20230920_pre.xml EX-101.PRE 9839
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eldn-20230920.xsd EX-101.SCH 2463
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eldn-20230920_lab.xml EX-101.LAB 13360
7 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20230920_htm.xml XML 4703
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 231267501
SIC: 2834 Pharmaceutical Preparations